D. E. Shaw Research (DESRES), based in New York City, develops and uses advanced computational technologies to understand the behavior of biologically and pharmaceutically significant molecules at an atomic level of detail, and to design precisely targeted, highly selective drugs for the treatment of various diseases. Among its core technologies is Anton, a proprietary special-purpose supercomputer that DESRES designed and constructed to vastly accelerate the process of molecular dynamics simulation. DESRES uses Anton machines and high-speed commodity hardware, together with machine learning methods and other computational techniques, in both internal and collaborative drug discovery programs. For more information, visit www.DEShawResearch.com.
Looking for a particular D. E. Shaw Research employee's phone or email?
The D. E. Shaw Research annual revenue was $15 million in 2026.
131 people are employed at D. E. Shaw Research.
D. E. Shaw Research is based in New York, New York.
The NAICS codes for D. E. Shaw Research are [541711, 5417, 54, 541, 54171].
The SIC codes for D. E. Shaw Research are [87, 873].